Sanofi snags another U.S. biotech asset with $3.7 billion deal for Principia Biopharma

Sanofi SA is to buy U.S.based Principia Biopharma Inc for around $3.7 billion, the companies announced on Monday, marking the French healthcare company's latest acquisition in the biotech sector.

from Top Business News- News18.com https://ift.tt/3g4Rwmm

• Tweet
• Share
• Share
• Share
• Share